Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Bioton SA - Key Facts

Bioton SA - Key Employees

Bioton SA - Major Products and Services

Bioton SA - History

Bioton SA - Company Statement

Bioton SA - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2 – Company Analysis

Company Overview

Bioton SA - Business Description

Bioton SA - Corporate Strategy

Bioton SA - SWOT Analysis

SWOT Analysis - Overview

Bioton SA - Strengths

Bioton SA - Weaknesses

Bioton SA - Opportunities

Bioton SA - Threats

Bioton SA - Key Competitors

Section 3 – Company’s Lifesciences Financial Deals and Alliances

Bioton SA, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Bioton SA, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Bioton SA, Recent Deals Summary

Section 4 – Appendix

Methodology

About GlobalData

Contact Us

Disclaimer

Bioton SA (BIO) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.

Highlights

Bioton SA (Bioton) manufactures medicines and pharmaceutical preparations and produces pharmaceutical substances. Its product portfolio includes antibiotics; anesthetic drugs and eye drops; recombinant human insulin in different forms; human growth hormone and orally taken anti-diabetic medicines. The company’s also provides strips for measurement of blood sugar and over-the-counter (OTC) preparations including diet supplements, products for particular nutritional uses and cosmetics for patients with certain health problems such as metabolic syndrome and diabetes. Bioton also undertakes research activities in the areas of genetic engineering, biotechnology, and pharmacology and offers in-licensing services. The company operates in Europe, Asia and Australia. Bioton is headquartered in Ozarow Mazowiecki, Masovian, Poland.

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.